Page last updated: 2024-09-02

exp3174 and exp-3179

exp3174 has been researched along with exp-3179 in 2 studies

Compound Research Comparison

Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010)
(exp3174)
Studies
(exp-3179)
Trials
(exp-3179)
Recent Studies (post-2010) (exp-3179)
2362943502

Protein Interaction Comparison

ProteinTaxonomyexp3174 (IC50)exp-3179 (IC50)
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.02
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.02
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.02

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schieffer, B; Schmidt, B1
Fukami, T; Hosomi, H; Iwamura, A; Nakajima, M; Yokoi, T1

Reviews

1 review(s) available for exp3174 and exp-3179

ArticleYear
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
    Journal of medicinal chemistry, 2003, Jun-05, Volume: 46, Issue:12

    Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2

2003

Other Studies

1 other study(ies) available for exp3174 and exp-3179

ArticleYear
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:5

    Topics: Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Benzbromarone; Biotransformation; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; HEK293 Cells; Hep G2 Cells; Hepatocytes; Humans; Losartan; NF-E2-Related Factor 2; Semicarbazides; Sensitivity and Specificity; Time Factors; Uricosuric Agents

2011